NCT07627399 Effectiveness of Best Care Practices in Acute Stroke in Conventional Hospitalization (BEST CARE ICTUS_HC)
| NCT ID | NCT07627399 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Malaga |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 700 participants |
| Start Date | 2026-05-12 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 700 participants in total. It began in 2026-05-12 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate whether a multicomponent nurse-led intervention (BEST CARE ICTUS\_HC) can reduce stroke-related complications and improve recovery in adults (18 years and older) hospitalized with an acute ischemic or hemorrhagic stroke in hospitals without specialized Stroke Units. The main questions it aims to answer are: 1. Does the implementation of the program increase the early and correct detection of swallowing difficulties (dysphagia) to prevent pneumonia? 2. Does the program reduce the severity of attention problems (hemineglect) and improve the patients' quality of life up to 6 months after discharge? Researchers will compare patients receiving the BEST CARE ICTUS\_HC program to patients receiving usual hospital care to see if this new approach improves patient safety and long-term functional recovery. Participants will: * Receive either the usual hospital care for stroke or the BEST CARE ICTUS\_HC nursing program, depending on the study phase of the hospital. * Be screened for swallowing problems using a standardized test before receiving any food or drink. * Be cared for in an adapted environment (FLECHA Project) that uses visual signs and room organization to help with orientation and safety. * Have their temperature, blood sugar, and blood pressure monitored under a strict specialized protocol. * Be contacted by phone 30 days and 6 months after leaving the hospital to answer questions about their health and quality of life.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 years or older. * Clinical diagnosis of acute ischemic or hemorrhagic stroke. * Admission to conventional hospitalization units (Internal Medicine) in regional hospitals without specialized Stroke Units. Exclusion Criteria: * Patients admitted for a cause other than stroke who develop a stroke during their hospital stay (in-hospital stroke). * Patients subjected to invasive neurological procedures. * Patients undergoing invasive procedures, such as thrombectomy, who require transfer to a referral hospital and remain there for more than 48 hours. * Patients with deterioration of the level of consciousness that prevents the performance of dysphagia testing. * Patients that have been taken care of by Nurses and Nursing Assistants with \>4 weeks of work experience in Stroke Units in the last 12 months
Contact & Investigator
JOSE MIGUEL MORALES-ASENCIO, PhD
PRINCIPAL INVESTIGATOR
Universidad de Málaga
Frequently Asked Questions
Who can join the NCT07627399 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07627399 currently recruiting?
Yes, NCT07627399 is actively recruiting participants. Contact the research team at jmmasen@uma.es for enrollment information.
Where is the NCT07627399 trial being conducted?
This trial is being conducted at Antequera, Spain, Marbella, Spain, Ronda, Spain, Málaga, Spain.
Who is sponsoring the NCT07627399 clinical trial?
NCT07627399 is sponsored by University of Malaga. The principal investigator is JOSE MIGUEL MORALES-ASENCIO, PhD at Universidad de Málaga. The trial plans to enroll 700 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.